TABLE 3

Functional cooperativity estimates for the interaction between BETP or Compound 2 and GLP-1R peptide ligands

Data derived from analysis of interaction concentration-response curves with an operational model of allosterism as defined in eqs. 4 and 5. pKb values are the negative logarithms for the functional affinity of the allosteric ligands; log αβ represents the composite cooperativity between the allosteric ligand and the orthosteric peptide ligand. Antilogarithms are shown in parentheses. Values represent the mean ± S.E.M. of four to six independent experiments performed in duplicate. Data were analyzed with one-way analysis of variance and Dunnett’s post test.

PathwayAllosteric LigandpKbLog αβ (αβ)
Exendin-4GLP-1(7–36)NH2OxyntomodulinGLP-1(1–36)NH2
cAMPBETP5.01 ± 0.040.45 ± 0.20 (2.8)0.31 ± 0.18 (2.0)1.21 ± 0.17 (16)*0.20 ± 0.12 (1.6)
Cpd25.43 ± 0.290.24 ± 0.30 (1.7)0.22 ± 0.28 (1.7)1.48 ± 0.27 (29)*0.31 ± 0.17 (2.0)
pERK1/2BETP5.46 ± 0.29–0.90 ± 0.21 (0.13)*–1.03 ± 0.23 (0.09)*−0.44 ± 0.19 (0.36)−1.85 ± 0.88 (0.01)
Cpd25.29 ± 0.19–0.77 ± 0.21 (5.9)–0.48 ± 0.17 (0.33)−0.21 ± 0.13 (0.62)−0.44 ± 0.20 (0.36)
iCa2+BETP4.83 ± 0.161.0 ± 0.26 (10)*0.58 ± 0.19 (3.8)0.23 ± 0.11 (1.7)NR
Cpd25.58 ± 0.380.28 ± 0.15 (1.9)–0.20 ± 0.15 (0.63)0.14 ± 0.16 (1.4)NR
β-Arr1BETP5.42 ± 0.17–0.05 ± 0.04 (0.89)–0.01 ± 0.02 (1.0)0.40 ± 0.17 (2.5)NR
Cpd25.27 ± 0.180.72 ± 0.18 (5.2)*1.07 ± 0.19 (12)*1.05 ± 0.14 (11)*NR
β-Arr2BETP5.38 ± 0.160.18 ± 0.26 (1.5)0.67 ± 0.18 (4.7)0.54 ± 0.19 (3.5)NR
Cpd25.30 ± 0.190.69 ± 0.20 (4.9)*1.06 ± 0.13 (11)*0.99 ± 0.19 (10)*NR
  • β-Arr, beta arrestin; BETP, 4-(3-benzyloxyphenyl)-2-ethylsulfinyl-6-(trifluoromethyl)pyrimidine; Compound 2, 6.7-dichloro-2-methylsulfonyl-3-tert-butylaminoquinoxaline; iCa2+, intracellular calcium; NR, no response; pKb, negative logarithms for the functional affinity of the allosteric ligands.

  • * P < 0.05.